Low incidence of second neoplasms among children diagnosed with acute lymphoblastic leukemia after 1983

Blood

Volumn 99, Issue 12, 2002, Pages 4257-4264

  Bhatia, Smita ^a,b,c,d,e,f   Sather, Harland N ^a,b,c,d,e   Pabustan, Olga B ^a,b,c,d,e   Trigg, Michael E ^a,b,c,d,e   Gaynon, Paul S ^a,b,c,d,e   Robison, Leslie L ^a,b,c,d,e  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b NEMOURS ALFRED I DUPONT HOSPITAL FOR CHILDREN   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d CHILDREN S HOSPITAL LOS ANGELES   (United States)

^e UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^f CHILDREN S ONCOLOGY GROUP   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE ANTIBIOTIC AGENT; CYCLOPHOSPHAMIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; ARTICLE; BRAIN CANCER; CANCER CHEMOTHERAPY; CANCER INCIDENCE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; INFANT; LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MYELODYSPLASIA; MYELOID LEUKEMIA; NEWBORN; NONHODGKIN LYMPHOMA; ONSET AGE; PAROTID GLAND CANCER; PRIORITY JOURNAL; RADIATION DOSE; SECOND CANCER; SEX DIFFERENCE; SOFT TISSUE SARCOMA; SOLID TUMOR; THYROID CANCER;

EID: 0037097806     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.V99.12.4257     Document Type: Article

References (62)

1. Incidence of cancer in children in the United States: Sex-, race-, and 1-year age-specific rates by histologic type
2. Memory and learning sequelae in long-term survivors of acute lymphoblastic leukemia: Association with attention deficits
3. Endocrine assessment in childhood acute lymphocytic leukemia
4. Evaluation of gonadal function following long-term treatment for acute lymphoblastic leukemia in girls
5. Testicular function in boys following chemotherapy for acute lymphoblastic leukemia
6. Normal or early development of puberty despite gonadal damage in children treated for acute lymphoblastic leukemia
7. Effects of radiation on ovarian function in long-term survivors of childhood acute lymphoblastic leukemia: A report from the Children's Cancer Study Group
8. Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood
9. Secondary neoplasms subsequent to Berlin-Frankfurt-Munster therapy of acute lymphoblastic leukemia in childhood: Significantly lower risk without cranial therapy
10. Second neoplasms after acute lymphoblastic leukemia in childhood
11. Second malignancy in acute lymphocytic leukemia
12. Secondary acute myeloid leukemia in children treated for acute lymphoid leukemia
13. Second malignancies in patients treated for childhood acute lymphoblastic leukemia
14. Second neoplasms in acute lymphoblastic leukemia
15. Secondary brain tumors in children treated for acute lymphoblastic leukemia at St. Jude Children's Research Hospital
16. Late anaplastic gliomas in children previously treated for acute lymphoblastic leukemia
17. Incidence of second malignant neoplasm in children: Results of an international study
18. Incidence of second primary tumour among childhood cancer survivors
19. Second malignant tumors after elective end of therapy for a first cancer in childhood: A multicenter study in Italy
20. Second malignant tumors following treatment during childhood and adolescence for cancer
21. Bone sarcomas linked to radiotherapy and chemotherapy in children
22. Astrocytoma as a second malignancy in patients with acute lymphoblastic leukemia
23. Late multifocal gliomas in adolescents previously treated for acute lymphoblastic leukemia
24. Brain tumors after cranial irradiation for childhood acute lymphoblastic leukemia. A 13-year experience from the Dana-Farber Cancer Institute and the Children's Hospital
25. Cerebral glioma after cranial prophylaxis for acute lymphoblastic leukemia
26. Second intracranial neoplasms following treatment of childhood acute lymphoblastic leukemia
27. High incidence of secondary brain tumors after radiotherapy and antimetabolites
28. Secondary brain tumors in children with ALL
29. Secondary brain tumors in children with ALL
30. Case report: Late aggressive meningioma following prophylactic cranial irradiation for acute lymphoblastic leukemia
31. Should therapy be intensified for patients with good risk ALL?
32. Double delayed intensification improves outcome in moderate risk pediatric- acute lymphoblastic leukemia (ALL): A Children's Cancer Group study, CCG1891
33. Improved outcome for children with T-lineage acute lymphoblastic leukemia after contemporary chemotherapy: A Children's Cancer Group study
34. Clinical features and treatment outcome of childhood T-lineage acute lymphoblastic leukemia according to the apparent maturational stage of T-lineage leukemic blasts: A Children's Cancer Group study
35. Biology and treatment of childhood T-lineage acute lymphoblastic leukemia
36. Dexamethasone (DEX) decreases central nervous system (CNS) relapse and improves event-free survival (EFS) in lower risk acute lymphoblastic leukemia (ALL)
37. Treatment outcome and prognostic factors for infants with acute lymphoblastic leukemia treated on two consecutive trials of the Children's Cancer Group
38. Augmented post-induction therapy for children with high-risk acute lymphoblastic leukemia and a slow response to initial therapy
39. Response of children with high-risk acute lymphoblastic leukemia treated with and without cranial irradiation: A report from the Children's Cancer Group
40. Treatment of patients with acute lymphoblastic leukemia with bulky extramedullary disease and T-cell phenotype or other poor prognostic features: Randomized controlled trial from the Children's Cancer Group
41. Augmented Berlin-Frankfurt-Munster therapy abrogates the adverse prognostic significance of low early response to induction chemotherapy for children and adolescents with acute lymphoblastic leukemia and unfavorable presenting features: A report from the Children's Cancer Group
42. Retrospective cohort studies
43. Second malignant neoplasms in patients treated for childhood leukemia
44. Second malignant neoplasms in survivors of childhood acute lymphocytic leukemia
45. Second malignant neoplasms in five-year survivors of childhood cancer: Childhood cancer survivor study
46. Equivalence of intrathecal chemotherapy and radiotherapy as central nervous system prophylaxis in children with acute leukemia: A Pediatric Oncology Group study
47. Central nervous system (CNS) prophylaxis in children with low risk acute lymphoblastic leukemia (ALL)
48. Primitive neuroectodermal tumors after prophylactic central nervous system irradiation in children: Association with an activated K-ras gene
49. Germline p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms
50. Cancer in relatives of children with central nervous system neoplasms
51. Multiple primary cancers in families with Li-Fraumeni syndrome
52. Parotid carcinoma as a second malignancy after treatment of childhood acute lymphoblastic leukemia
53. Second thyroid neoplasms after prophylactic cranial irradiation for acute lymphoblastic leukemia
54. Papillary thyroid carcinoma: Demographics, treatment, and outcome in eleven pediatric patients treated at a single institution
55. Papillary thyroid carcinoma after total body irradiation
56. Thyroid carcinoma and acute lymphoblastic leukemia in childhood
57. Thyroid carcinoma following treatment for acute lymphoblastic leukemia
58. Breast cancer and other second neoplasms after childhood Hodgkin's disease
59. Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease
60. Secondary Hodgkin's disease in childhood acute lymphoblastic leukemia
61. Hodgkin's disease in a child with acute lymphoblastic leukemia